SCHEMBL25252335

SCHEMBL25252335

N#Cc1nc([C@@H]2CCON2)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25255412 0.68
Trifluoroacetic Acid SCHEMBL25296943 0.66 RAB9A (0.33)
Hydrochloric Acid SCHEMBL25255172 0.66 USP30 (0.35)
SCHEMBL31200178 0.66 MAP3K12 (0.34)
SCHEMBL18921367 0.62 PGR (0.30)
SCHEMBL18921421 0.62 KCNH2 (0.36)
SCHEMBL31200403 0.61 ENPP3 (0.33)
SCHEMBL22232716 0.61 TRPV1 (0.34)
SCHEMBL22256525 0.61 CHRNB2 (0.36)
SCHEMBL25428194 0.61 CHRNB2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547281-A Isoxazolidines as RIPK1 inhibitors and uses thereof 赛诺菲 2023-08-04 CN disclosed
US-20230219937-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-07-13 US disclosed
US-20230219937-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-07-13 US disclosed
EP-4157835-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-04-05 EP disclosed